NETosis-PANoptosis Crosstalk in Colitis-Associated Colorectal Cancer: Mechanistic Links, Biomarkers, and Therapeutic Prospects
Journal of Inflammation Research · 2026-10 · Volume 19 · 1-36
DOI: 10.2147/jir.s640556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Jing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Third Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People's Republic of China.
- The First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People's Republic of China.
- The Third Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People's Republic of China.
ORCID-Profile: Jing Wang, Bowen Tang
Zitieren
APA
Wang, J., Tang, B., Zhang, W., Kong, A., & Sui, N. (2026). NETosis-PANoptosis Crosstalk in Colitis-Associated Colorectal Cancer: Mechanistic Links, Biomarkers, and Therapeutic Prospects. Journal of Inflammation Research, Volume 19, 1-36. https://doi.org/10.2147/jir.s640556
Vancouver
Wang J, Tang B, Zhang W, Kong A, Sui N. NETosis-PANoptosis Crosstalk in Colitis-Associated Colorectal Cancer: Mechanistic Links, Biomarkers, and Therapeutic Prospects. Journal of Inflammation Research. 2026;Volume 19:1-36. doi:10.2147/jir.s640556
BibTeX
@article{Wang2026,
author = {Wang, Jing and Tang, Bowen and Zhang, Wenwen and Kong, Ailin and Sui, Nan},
title = {NETosis-PANoptosis Crosstalk in Colitis-Associated Colorectal Cancer: Mechanistic Links, Biomarkers, and Therapeutic Prospects},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--36},
doi = {10.2147/jir.s640556}
}
EUVIMED